MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 113 filers reported holding MERUS N V in Q3 2023. The put-call ratio across all filers is 2.34 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,662 | -36.7% | 70,482 | -29.3% | 0.08% | -31.6% |
Q2 2023 | $2,625 | +27.6% | 99,702 | -10.9% | 0.11% | +17.5% |
Q1 2023 | $2,058 | +46.8% | 111,858 | +23.5% | 0.10% | +24.4% |
Q4 2022 | $1,402 | -99.9% | 90,597 | +75.5% | 0.08% | +25.8% |
Q3 2022 | $1,034,000 | -2.9% | 51,617 | +9.8% | 0.06% | -22.5% |
Q2 2022 | $1,065,000 | -5.8% | 47,023 | +9.9% | 0.08% | +8.1% |
Q1 2022 | $1,131,000 | +138.6% | 42,793 | +186.9% | 0.07% | +25.4% |
Q4 2021 | $474,000 | +35.8% | 14,918 | -6.0% | 0.06% | +28.3% |
Q3 2021 | $349,000 | – | 15,868 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $32,048,000 | 13.34% |
Lynx1 Capital Management LP | 613,071 | $12,280,000 | 11.08% |
Aquilo Capital Management, LLC | 1,507,109 | $30,187,000 | 10.88% |
COMMODORE CAPITAL LP | 2,615,762 | $52,394,000 | 8.42% |
MPM BioImpact LLC | 918,310 | $18,394,000 | 4.36% |
BVF INC/IL | 3,444,420 | $68,992,000 | 2.85% |
Boxer Capital, LLC | 1,900,000 | $38,057,000 | 2.14% |
Opaleye Management Inc. | 253,200 | $5,072,000 | 2.10% |
SILVERARC CAPITAL MANAGEMENT, LLC | 295,136 | $5,912,000 | 2.00% |
TCG Crossover Management, LLC | 300,000 | $6,009,000 | 1.80% |